This compound is a deuterium-labeled derivative of a uridine analog, characterized by the incorporation of eleven deuterium atoms at specific positions within a pentyl side chain. It functions as a modified nucleoside species featuring a fluorinated pyrimidine base and a pentose sugar ring, configured stereochemically as indicated by its structural markers.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 1132662-08-8
B-[(1R)-3-Methyl-1-[[(2R)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic Acid
active pharmaceutical ingredient
(2S)-5-amino-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-1-((2S,3S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-((2-aminoacetyl)amino)-3-carboxypropanoyl)amino)-3-phenylpropanoyl)amino)-4-carboxybutanoyl)amino)-4-carboxybutanoyl)amino)-3-methylpentanoyl)pyrrolidine-2-carbonyl)amino)-4-carboxybutanoyl)amino)-4-carboxybutanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)-4-methylpentanoyl)amino)-5-oxopentanoic acid
Thrombin inhibitor anticoagulant peptide
Quizartinib dihydrochloride
active pharmaceutical ingredient
Dasabuvir
active pharmaceutical ingredient
Capecitabina
active pharmaceutical ingredient
1,1,2,2,3,3,4,4,5,5,5-undecadeuteriopentyl N-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxopyrimidin-4-yl]carbamate
GAGWJHPBXLXJQN-XSFNBKHLSA-N
[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])OC(=O)NC1=NC(=O)N(C=C1F)[C@H]2[C@@H]([C@@H]([C@H](O2)C)O)O